Thomas Elter, Julia Kilp, Peter Borchmann, Holger Schulz, Michael Hallek, Andreas Engert. Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia. haematol [Internet]. 2008Dec.31 [cited 2024Apr.25];94(1):150-2. Available from: https://haematologica.org/article/view/5135